Not finding it? Sign in to also search OpenAlex live.
-
Cytogenetic and molecular risk-driven conditioning intensity in acute myeloid leukemia patients undergoing stem cell transplantation with post-transplant cyclophosphamide: a study from the acute leukemia working party of the EBMT2025 Bone Marrow Transplantation article Medicine Hematopoietic Stem Cell Transplantation Open access
Jaime Sanz, Myriam Labopin, Jurjen Versluis, Didier Blaise, Lorenzo Lazzari, Juan Montoro, +14 more
5citations -
Prophylactic Donor Lymphocyte Infusion in Patients after Allogeneic Stem Cell Transplantation with Post-Transplant Cyclophosphamide Is Associated with Low Relapse Risk and Excellent Survival in Patients below 65 Years with Acute Myeloid Leukemia and High-Risk Myelodysplasia
Peter A. von dem Borne, Tjeerd J.F. Snijders, Daniëlle van Lammeren, Janneke Tijmensen, Erwin V. Planken, Henriëtte Levenga, +9 more
1citations -
Association between cardiovascular risk factors and intracranial hemorrhage in patients with acute leukemia2021 European Journal Of Haematology article Medicine Intracerebral and Subarachnoid Hemorrhage Research Open access
Loes L. Cornelissen, Aukje L. Kreuger, Camila Caram‐Deelder, Menno Volkert Huisman, Rutger A. Middelburg, Jean‐Louis Kerkhoffs, +6 more
5citations -
The impact of donor type on the outcome of pediatric patients with very high risk acute lymphoblastic leukemia. A study of the ALL SCT 2003 BFM-SG and 2007-BFM-International SG2020 Bone Marrow Transplantation article Medicine Hematopoietic Stem Cell Transplantation Open access
Jean‐Hugues Dalle, Adriana Balduzzi, Peter Bader, Anna Pieczonka, Isaac Yaniv, Arjan C. Lankester, +11 more
15citations -
Real-World Risk of Myelodysplastic Syndrome/Acute Myeloid Leukemia and Other Second Primary Malignancies in Patients with Epithelial Ovarian Cancer Treated with Niraparib Maintenance Therapy: Results from a Postauthorization Safety Study
Maurice J. D. L. van der Vorst, Constanza Maximiano Alonso, Tirza Areli Calderón Boyle, Jeanne M. Schilder, Izabela A. Malinowska, Guilan Ye, +8 more
0citations -
Trends in Allogeneic Transplantation for Favorable Risk Acute Myeloid Leukemia in First Complete Remission: A Longitudinal Study of > 15 Years from the ALWP/EBMT2024 Transplantation and Cellular Therapy article Medicine Acute Myeloid Leukemia Research Open access
Arnon Nagler, Myriam Labopin, Urpu Salmenniemi, Depei Wu, Didier Blaise, Alessandro Rambaldi, +15 more
0citations -
POSTER: MPN-756: CPX-351 vs Standard of Care as Bridging to AlloHCT in Patients With Higher-Risk Myelodysplastic Neoplasms or Oligoblastic Acute Myeloid Leukemia: Results of the Randomized Phase 2 PALOMA Study
Uwe Platzbecker, Martina Margrit Crysandt, Martin Kaufmann, Andreas Rank, Christoph Röllig, Hartmut Döhner, +30 more
1citations -
Trends in allogeneic transplantation for favorable risk acute myeloid leukemia in first remission: a longitudinal study of >15 years from the ALWP of the EBMT2024 Bone Marrow Transplantation article Medicine Hematopoietic Stem Cell Transplantation Open access
Arnon Nagler, Myriam Labopin, Urpu Salmenniemi, Depei Wu, Didier Blaise, Alessandro Rambaldi, +15 more
3citations -
Effect of invasive aspergillosis on risk for different causes of death in older patients with acute myeloid leukaemia or high-risk myelodysplastic syndrome
Rebecca van Grootveld, Valentina Masarotto, Peter A. von dem Borne, Nicole M. A. Blijlevens, Dana A. Chitu, Martha T. van der Beek, +2 more
2citations -
Complex karyotype but not other cytogenetic abnormalities is associated with worse posttransplant survival of patients with nucleophosmin 1‐mutated acute myeloid leukemia: A study from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party
Nour M. Moukalled, Myriam Labopin, Jurjen Versluis, Gèrard Socié, Didier Blaise, Urpu Salmenniemi, +12 more
7citations -
Outcomes of 544 Patients with t(6;9)/DEK::NUP214 acute myeloid leukemia undergoing allogeneic stem cell transplantation: an EBMT study on behalf of the acute leukemia working party (ALWP) and the pediatric diseases working party (PDWP)
Fabio Andreozzi, Jacques‐Emmanuel Galimard, Johan A. Maertens, Mahmoud Deeb Aljurf, Katherine Clesham, J L Valero Sanz, +17 more
1citations -
Dutch ALL11 Study: Improved Outcome for Acute Lymphoblastic Leukemia By Prolonging Therapy for IKZF1 Deletion and Decreasing Therapy for ETV6::RUNX1, Down Syndrome and Prednisone Poor Responders
Rob Pieters, Hester A. de Groot‐Kruseman, Femke Verwer, Merian van Overveld, Edwin Sonneveld, Marta F. Fiocco, +10 more
2citations